Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma.

Nedime Serakinci; Rikke Christensen; Flemming Brandt Sørensen; Frederik Dagnæs-Hansen; Umut Fahrioglu; Miroslav Hajek; Tinna Herløv  Jensen; Steen Kølvraa; Nicol W Keith

doi:10.1089/cbr.2011.1024

Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma.

Nedime Serakinci, Rikke Christensen, Flemming Brandt Sørensen, Frederik Dagnæs-Hansen, Umut Fahrioglu, Miroslav Hajek, Tinna Herløv Jensen, Steen Kølvraa, Nicol W Keith

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Cancer Biotherapy & Radiopharmaceuticals
Vol/bind	26
Nummer	6
Sider (fra-til)	767
Antal sider	773
ISSN	1084-9785
DOI	https://doi.org/10.1089/cbr.2011.1024
Status	Udgivet - 6 dec. 2011

Adgang til dokumentet

10.1089/cbr.2011.1024

Citationsformater

@article{c30afa95f408416ea5f6d3da70bddb56,

title = "Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma.",

author = "Nedime Serakinci and Rikke Christensen and S{\o}rensen, {Flemming Brandt} and Frederik Dagn{\ae}s-Hansen and Umut Fahrioglu and Miroslav Hajek and Jensen, {Tinna Herl{\o}v} and Steen K{\o}lvraa and Keith, {Nicol W}",

year = "2011",

month = dec,

day = "6",

doi = "10.1089/cbr.2011.1024",

language = "English",

volume = "26",

pages = "767",

journal = "Cancer Biotherapy & Radiopharmaceuticals",

issn = "1084-9785",

publisher = "Mary Ann Liebert Inc.",

number = "6",

}

TY - JOUR

T1 - Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma.

AU - Serakinci, Nedime

AU - Christensen, Rikke

AU - Sørensen, Flemming Brandt

AU - Dagnæs-Hansen, Frederik

AU - Fahrioglu, Umut

AU - Hajek, Miroslav

AU - Jensen, Tinna Herløv

AU - Kølvraa, Steen

AU - Keith, Nicol W

PY - 2011/12/6

Y1 - 2011/12/6

U2 - 10.1089/cbr.2011.1024

DO - 10.1089/cbr.2011.1024

M3 - Journal article

C2 - 21877908

SN - 1084-9785

VL - 26

SP - 767

JO - Cancer Biotherapy & Radiopharmaceuticals

JF - Cancer Biotherapy & Radiopharmaceuticals

IS - 6

ER -